Gene Therapy Innovations for Cancer Research

Gene Therapy Innovations for Cancer Research

RELEASE DATE
27-Jul-2018
REGION
Global
Research Code: D758-00-84-00-00
SKU: HC03061-GL-TA_22222
$250.00
In stock
SKU
HC03061-GL-TA_22222
$250.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This Genetic Technology TechVision Opportunity Engine (TOE) depicts gene therapy innovations for cancer research. The corresponding clinical trials scenario for lysosomal storage diseases is also depicted.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: PARP inhibitors, ovarian cancer therapy, dendritic cell therapy, humanized antibody, anaphylaxia

Table of Contents

Recent Advances in Gene Therapies that Address Rare and Genetic Diseases

  • PARP Inhibitors Reshaping Ovarian Cancer Therapy
  • Combining Dengue Fever Virus with Dendritic Cell Therapy
  • Novel Humanized Antibody to Treat Solid Tumors
  • Therapeutic Approach to the Urgent Treatment of Anaphylaxia

Clinical Trial Analysis and Key Contacts

  • Clinical Trial Analysis for Lysosomal Storage Disease
  • Key Contacts
Related Research
This Genetic Technology TechVision Opportunity Engine (TOE) depicts gene therapy innovations for cancer research. The corresponding clinical trials scenario for lysosomal storage diseases is also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: PARP inhibitors, ovarian cancer therapy, dendritic cell therapy, humanized antibody, anaphylaxia
More Information
No Index No
Podcast No
WIP Number D758-00-84-00-00
Is Prebook No